Arrival : Arrival Advances U.S. Commercialization Plans Through Business Combination with Kensington Capital Acquisition Corp. V

[ad_1] Arrival (Nasdaq: ARVL) has entered into a business combination agreement with Kensington Capital Acquisition Corp. V (NYSE: KCGI.U). Upon closing, the combined company’s ordinary shares are expected to be…

Drug manufacturing facility gets green light thanks to federal dollars

[ad_1] Alberta’s burgeoning biomanufacturing and life sciences industry got an $80.5-million boost in federal funding today, putting it at the centre of efforts to commercialize new discoveries and give Canadians…